James S. Scibetta serves as Executive at Pacira Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, James S. Scibetta has executed 60 insider transactions totaling $11.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 19, 2021 involved transacting 4,800 shares valued at $0.
James S. Scibetta currently holds 625,958 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James S. Scibetta has been a net seller of PCRX stock. They have purchased $435.5K and sold $10.9M worth of shares.
James S. Scibetta's most recent insider trade was on Jun 19, 2021, when they sold 4,800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 23, 2020 | MTNB | $0 | Other | 3,600 | $N/A | Discretionary |
| Dec 31, 2019 | MTNB | $0 | Award | 8,260 | $N/A | Discretionary |
| Sep 30, 2019 | MTNB | $0 | Award | 29,739 | $N/A | Discretionary |
| Aug 21, 2019 | AQST | $3.4K | Purchase | 900 | $3.81 | Discretionary |
| Aug 20, 2019 | AQST | $43.0K | Purchase | 11,310 | $3.80 | Discretionary |
| Aug 19, 2019 | AQST | $40.6K | Purchase | 10,761 | $3.77 | Discretionary |
| Jun 30, 2019 | MTNB | $0 | Award | 21,879 | $N/A | Discretionary |
| Jun 21, 2019 | MTNB | $0 | Other | 2,400 | $N/A | Discretionary |
| Mar 31, 2019 | MTNB | $0 | Award | 17,202 | $N/A | Discretionary |
| Dec 31, 2018 | MTNB | $0 | Award | 31,513 | $N/A | Discretionary |
| Oct 1, 2018 | MTNB | $0 | Award | 20,381 | $N/A | Discretionary |
| Jun 29, 2018 | MTNB | $0 | Award | 43,203 | $N/A | Discretionary |
| Mar 30, 2018 | MTNB | $0 | Award | 24,672 | $N/A | Discretionary |
| Sep 7, 2017 | MTNB | $6.5K | Purchase | 5,000 | $1.29 | Discretionary |
| Jun 5, 2017 | PCRX | $85.2K | Sale | 1,966 | $43.32 | Discretionary |
| May 15, 2017 | PCRX | $109.8K | Option Exercise | 20,000 | $5.49 | Discretionary |
| May 15, 2017 | PCRX | $1.0M | Sale | 20,000 | $51.20 | Discretionary |
| Jan 17, 2017 | PCRX | $96.8K | Option Exercise | 17,627 | $5.49 | Discretionary |
| Jan 17, 2017 | PCRX | $576.0K | Sale | 15,003 | $38.39 | Discretionary |
| Jan 17, 2017 | PCRX | $3.8K | Option Exercise | 2,373 | $1.61 | Discretionary |
| Jan 17, 2017 | PCRX | $194.7K | Sale | 4,997 | $38.97 | Discretionary |
| Nov 15, 2016 | PCRX | $32.2K | Option Exercise | 20,000 | $1.61 | Discretionary |
| Nov 15, 2016 | PCRX | $730.0K | Sale | 20,000 | $36.50 | Discretionary |
| Aug 15, 2016 | PCRX | $14.7K | Option Exercise | 9,123 | $1.61 | Discretionary |
| Aug 15, 2016 | PCRX | $1.1M | Sale | 25,000 | $45.21 | Discretionary |
| Aug 15, 2016 | PCRX | $25.6K | Option Exercise | 15,877 | $1.61 | Discretionary |
| Jun 15, 2016 | PCRX | $0 | Award | 16,250 | $N/A | Discretionary |
| Sep 11, 2015 | PCRX | $306.9K | Purchase | 5,000 | $61.37 | Discretionary |